MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02525cam a2200421 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
506151482 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200929094635.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100204s2011 stka b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2010005022 |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
|---|
| National bibliography number |
GBB099734 |
| Source |
bnb |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780443072338 (pbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0443072337 (pbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780443072338 (international) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0443072337 (international) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)506151482 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
YDX |
| -- |
NLM |
| -- |
UKM |
| -- |
YDXCP |
| -- |
MXC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS403 |
| Item number |
.P47 2011 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
2011 D-399 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 744 |
| Item number |
P5342 2011 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
22 |
| Item number |
P |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmaceutical chemistry / |
| Statement of responsibility, etc |
edited by David G. Watson. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
International edition. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Edinburgh ; |
| Name of publisher, distributor, etc |
Churchill Livingstone/Elsevier, |
| Date of publication, distribution, etc |
[2011] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
ix, 641 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
25 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
|---|
| General note |
pharmacy bookfair2015 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1 Bond type and bond strength -- 2 Hydrocarbons: alkanes, alkenes, aromatics and alkylhalides -- 3 Amines -- 4 Neutral and acidic nitrogen compounds -- 5 Oxygen- and sulphur-containing functional groups -- 6 Protein structure and its relevance to drug action -- 7 DNA structure and its importance to drug action -- 8 Drug absorption, distribution, metabolism and excretion -- 9 Structure, activity and drug design -- 10 Drugs affecting the adrenergic system -- 11 Drugs exerting non-adrenergic effects on cardiac output and vascular tone -- 12 Drugs interacting with mammalian enzymes -- 13 Central nervous system depressants -- 14 Analgesics -- 15 Local anaesthetics -- 16 Anti-cholinergic agents -- 17 Anti-histamine drugs --18 CNS stimulants and CNS-active drugs affecting the serotonergic system -- 19 Drugs affecting haemostasis and thrombosis -- 20 Drugs affecting the endocrine system -- 21 Anticancer drugs -- 22 Antimicrobial chemotherapy: A. Antibiotics. B. Antituberculosis drugs -- 23 Antiviral drugs -- 24 Antifungal chemotherapy -- 25 Antiparasitic drugs -- 26 Vitamins and minerals -- 27 Biotechnologically produced products -- 28 Drug and gene delivery systems -- 29 Alcohol |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemistry, Pharmaceutical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Watson, David G., |
| Dates associated with a name |
1952-, |
| Relator term |
editor. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1758">http://repository.fue.edu.eg/xmlui/handle/123456789/1758</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |